To assess the knowledge and practice preferences of anaphylaxis treatment among pediatric intensivists in 5 Brazilian pediatric intensive care unit (PICU) settings.
Study Design:
The cohort was a cross-sectional sample from 5 PICUs; a 7-question survey was personally applied to participants regarding their professional clinical experience and the first-line drug choices when treating an anaphylaxis episode.
Results:
Of 43 participant physicians, the majority (83.8%) correctly identified epinephrine as the treatment of choice for anaphylaxis, yet only 41.9% chooses the intramuscular route of administration.
Conclusion:
This study shows that the knowledge of anaphylaxis treatment is deficient among pediatric intensivists in Brazil. The dissemination of recent World Allergy Organization guidelines on anaphylaxis should be encouraged.
SimonsFEArdussoLRBilòMB. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol. 2011;127(3):587–593.e1–e22.
2.
SimonsFEArdussoLRBilòMB. 2012 Update: World Allergy Organization (WAO) guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012;12(4):389–399.
3.
SimonsFEArdussoLRDimovV. World Allergy Organization anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol. 2013;162(3):193–204.
4.
SimonsFEArdussoLRBilòMB. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014;7(1):9.
5.
MuraroARobertsGWormM. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026–1045.
6.
LiebermanPNicklasRARandolphC. Anaphylaxis—a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341–384.
WoodRACamargoCAJrLiebermanP. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133(2):461–467.
9.
TurnerPJGowlandMHSharmaV. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135(4):956–963.e1.
10.
StoreyPFitzharrisP. Adrenaline in anaphylaxis: overtreatment in theory, undertreatment in reality. Postgrad Med J. 2015;91(1071):1–2.
11.
GalvaoVRCastellsMC. Hypersensitivity to biological agents—updated diagnosis, management, and treatment. J Allergy Clin Immunol Pract. 2015;3(2):175–185.
12.
AunMVBlancaMGarroLS. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414–420.
13.
MoriFPecorariLPantanoS. Azithromycin anaphylaxis in children. Int J Immunopathol Pharmacol. 2014;27(1):121–126.
14.
ReitterMPetitpainNLatarcheC. Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis. Allergy. 2014;69(7):954–959.
15.
DemolyPAdkinsonNFBrockowK. International consensus on drug allergy. Allergy. 2014;69(4):420–437.
16.
ClarkSWeiWRuddersSACamargoCAJr. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol. 2014;134(5):1125–1130.
17.
BanerjiARuddersSClarkSWeiWLongAACamargoCAJr. Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up. J Allergy Clin Immunol Pract. 2014;2(1):46–51.
18.
CampbellRLLiJTNicklasRASadostyAT; Members of the Joint Task Force; Practice Parameter Workgroup. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(6):599–608.
19.
de SilvaILMehrSSTeyDTangML. Paediatric anaphylaxis: a 5-year retrospective review. Allergy. 2008;63(8):1071–1076.
20.
RussellSMonroeKLosekJD. Anaphylaxis management in the pediatric emergency department: opportunities for improvement. Pediatr Emerg Care. 2010;26(2):71–76.
21.
PrabhuSBYasmeenM. Treatment of anaphylaxis in adults: a questionnaire survey at S. Nijalingappa Medical College Hospital, Bagalkot, India. J Clin Diagn Res. 2010;4(6):3474–3479.
22.
GrossmanSLBaumannBMGarcia PeñaBMLinaresMYGreenbergBHernandez-TrujilloVP. Anaphylaxis knowledge and practice preference of pediatric emergency medicine physicians: a national survey. J Pediatr. 2013;163(3):841–846.
23.
HaymoreBRCarrWWFrankWT. Anaphylaxis and epinephrine prescribing patterns in a military hospital: underutilization of the intramuscular route. Allergy Asthma Proc. 2005;26(5):361–365.
SoléDIvancevichJCCardonaV. Knowledge of anaphylaxis among ibero-American physicians: results of the Ibero-American Online Survey for Physicians on the management and treatment of anaphylaxis (IOSPTA)—Latin American society of Allergy, Asthma & Immunology (LASAAI). J Investig Allergol Clin Immunol. 2013;23(6):441–443.
26.
CampbellRLBellolioMFKnutsonBD. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015;3(1):76–80.
27.
SimonsFEEbisawaMSanchez-BorgesM. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;8(1):32.
28.
SimonsFERSampsonHA. Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol. 2015;135(5):1125–1131.
29.
DhamiSPanesarSSRobertsG. Management of anaphylaxis: a systematic review. Allergy. 2014;69(2):168–175.
30.
LangESWyerPCHaynesRB. Knowledge translation: closing the evidence-to-practice gap. Ann Emerg Med. 2007;49(3):355–363.
